Correction to Figure 1 in the PANORAMA Trial Report on Intravitreal Aflibercept for Severe Nonproliferative Diabetic Retinopathy
-
October 1, 2026
October 1, 2026
October 1, 2026
A healthy 38-year-old woman maintained 20/20 vision despite retinal hemorrhage and venous tortuosity.
October 15, 2026